UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by US Bancorp DE


Share on StockTwits

US Bancorp DE boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,065,251 shares of the healthcare conglomerate’s stock after buying an additional 4,089 shares during the quarter. UnitedHealth Group accounts for about 0.8% of US Bancorp DE’s investment portfolio, making the stock its 25th largest position. US Bancorp DE owned approximately 0.11% of UnitedHealth Group worth $396,351,000 as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of UNH. FMR LLC boosted its stake in UnitedHealth Group by 0.6% in the 4th quarter. FMR LLC now owns 52,565,986 shares of the healthcare conglomerate’s stock worth $18,433,841,000 after purchasing an additional 295,642 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in UnitedHealth Group by 5.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 38,003,233 shares of the healthcare conglomerate’s stock worth $13,318,678,000 after purchasing an additional 1,881,407 shares during the period. Alliancebernstein L.P. boosted its stake in shares of UnitedHealth Group by 5.2% during the 4th quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock valued at $4,027,639,000 after buying an additional 569,142 shares during the period. Norges Bank acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at $3,397,896,000. Finally, Bank of New York Mellon Corp boosted its stake in shares of UnitedHealth Group by 2.4% during the 4th quarter. Bank of New York Mellon Corp now owns 8,858,179 shares of the healthcare conglomerate’s stock valued at $3,106,385,000 after buying an additional 207,865 shares during the period. Hedge funds and other institutional investors own 86.03% of the company’s stock.

Shares of UnitedHealth Group stock traded up $0.61 during trading on Tuesday, hitting $406.51. 29,765 shares of the company’s stock traded hands, compared to its average volume of 3,262,127. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.82. The firm’s fifty day moving average price is $378.48 and its 200 day moving average price is $349.25. UnitedHealth Group Incorporated has a twelve month low of $273.71 and a twelve month high of $406.77. The company has a market cap of $383.70 billion, a PE ratio of 23.31, a PEG ratio of 1.55 and a beta of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share for the quarter, beating the consensus estimate of $4.38 by $0.93. The business had revenue of $70.20 billion for the quarter, compared to analyst estimates of $69.13 billion. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The firm’s revenue was up 9.0% on a year-over-year basis. During the same period in the previous year, the business earned $3.72 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 16.75 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 23rd. Shareholders of record on Monday, March 15th were given a $1.25 dividend. The ex-dividend date was Friday, March 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.23%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.09%.

A number of equities research analysts have issued reports on the stock. Barclays lifted their target price on shares of UnitedHealth Group from $405.00 to $435.00 and gave the company an “overweight” rating in a research note on Thursday, April 22nd. Stephens lifted their price objective on shares of UnitedHealth Group from $415.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday, April 22nd. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $462.00 to $515.00 and gave the company an “overweight” rating in a research note on Thursday, April 22nd. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $375.00 to $440.00 and gave the company an “outperform” rating in a research note on Thursday, April 22nd. Finally, Mizuho lifted their price objective on shares of UnitedHealth Group from $380.00 to $394.00 and gave the company a “buy” rating in a research note on Thursday, April 15th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and an average price target of $409.61.

In other news, CAO Thomas E. Roos sold 5,301 shares of the company’s stock in a transaction that occurred on Tuesday, April 27th. The shares were sold at an average price of $394.66, for a total transaction of $2,092,092.66. Following the transaction, the chief accounting officer now directly owns 58,589 shares in the company, valued at $23,122,734.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, April 19th. The stock was sold at an average price of $391.25, for a total transaction of $978,125.00. Following the transaction, the director now owns 154,181 shares in the company, valued at $60,323,316.25. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 20,420 shares of company stock worth $7,532,962. Company insiders own 0.80% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.

Featured Story: Stock Market – What is a circuit breaker?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.